digital token vs cryptocurrency- Top Knowledge

Jingmen, the Yiwei Lithium Energy Super Energy Storage Factory, was put into operation, with the largest production capacity in Central China. Following the opening and operation of Jingjing High-speed Railway, on December 10th, the Yiwei Lithium Energy 60GWh Super Energy Storage Factory project was officially put into operation in the new energy and new materials industrial park of Duodao District, Jingmen High-tech Zone, becoming a lithium battery production base with the largest production capacity and the longest industrial chain in Central China. The total investment of this project is 10.8 billion yuan, and the first phase covers an area of about 700 mu. It mainly produces MB56 large iron-lithium energy storage batteries, and its cell capacity and cycle times are 25% and 20% higher than those of the same industry products respectively, which are widely used in electric energy storage, ship energy storage and other fields. Taking an electric ship as an example, the voyage distance can be increased by about 40% by using MB56 battery, and the battery life can be extended by about two years.Sources: Thailand's Cabinet approves the draft of the lowest corporate tax law in the world.German Foreign Ministry Spokesperson: Berlin will hold the Weimar Triangle Foreign Ministers' Meeting on Thursday, and representatives from Italy, Spain, Britain and the European Union will also attend.

Modern Investment: Xu Qing, the independent director of the company, was subject to disciplinary review and supervision investigation. According to the announcement of Modern Investment, Xu Qing, the independent director of the company, was suspected of serious violation of discipline and law, and is currently subject to disciplinary review by the Disciplinary Committee of Hunan Branch of Industrial and Commercial Bank of China and supervision investigation by Zhuzhou Municipal Supervision Committee. Xu Qing did not hold any other positions in the company except as an independent director, chairman of the Nomination Committee of the Board of Directors, member of the Strategy Committee of the Board of Directors and member of the Audit Committee of the Board of Directors, and did not participate in the daily operation and management of the company. The company will pay attention to the subsequent progress and fulfill its information disclosure obligations in a timely manner in strict accordance with relevant regulations.Market News: US Secretary of State Blinken will travel to Jordan and Turkey for talks on the Syrian issue on Wednesday.Wanfang Development: A supplementary agreement on equity transfer of RMB 12.3 million was signed, and Wanfang Development announced that the company held the 66th meeting of the 9th Board of Directors on December 11th, 2024, at which the Proposal on the Progress of Selling a wholly-owned subsidiary and Signing a Supplementary Agreement was reviewed and approved. The Company signed Supplementary Agreement III to the Equity Transfer Agreement with Beijing Tianyuan and Beijing Baiyu, and Beijing Baiyu will pay the remaining equity transfer amount of RMB 12.3 million to the Company before December 31, 2025. As of the disclosure date of the announcement, Beijing Baiyu has paid 77.7 million yuan of equity transfer to the company, and the remaining 12.3 million yuan of equity transfer has not been paid. The company has transferred its 86.3333% equity of Beijing Tianyuan to Beijing Baiyu, so far, the company holds 13.6667% equity of Beijing Tianyuan.

ADB approved a loan of US$ 200 million for power infrastructure construction in Pakistan.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)Ningbo Founder: The company intends to use its own or self-raised funds to purchase 40% equity of Junpeng Communication from related party Pengxin Chuangzhan in cash. Ningbo Founder announced that the company intends to use its own or self-raised funds to purchase 40% equity of Junpeng Communication from related party Pengxin Chuangzhan in cash.